Astrazeneca Admits Covishield Jab Raises TTS Risk Should You Be Worried? (Lead) menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
British pharma bigwig AstraZeneca has admitted that its COVID-19 vaccine can lead to a rare blood clotting condition known as Thrombosis with Thrombocytopenia Syndrome (TTS).
AstraZeneca admits Covishield jab raises TTS risk Should you be worried? newkerala.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newkerala.com Daily Mail and Mail on Sunday newspapers.
AstraZeneca, in collaboration with the University of Oxford, admits its Covid-19 vaccine can cause a rare side effect, Thrombosis with Thrombocytopenia Syndrome (TTS). The admission comes amidst a lawsuit alleging severe harm and deaths caused by the vaccine. Kate, wife of a victim, demands an apology and fair compensation after a three-year struggle. The lawsuit, involving fifty-one cases, seeks around £100 million in compensation.
Clot in blood vessels occurs in rare cases with certain vaccines: Medical Expert amid reports over AstraZeneca aninews.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aninews.in Daily Mail and Mail on Sunday newspapers.